000 | 01465 a2200421 4500 | ||
---|---|---|---|
005 | 20250514162102.0 | ||
264 | 0 | _c20040107 | |
008 | 200401s 0 0 eng d | ||
022 | _a0007-0920 | ||
024 | 7 |
_a10.1038/sj.bjc.6601366 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCameron, D A | |
245 | 0 | 0 |
_aModerate neutropenia with adjuvant CMF confers improved survival in early breast cancer. _h[electronic resource] |
260 |
_bBritish journal of cancer _cNov 2003 |
||
300 |
_a1837-42 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAge of Onset |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
650 | 0 | 4 |
_aBreast Neoplasms _xdiagnosis |
650 | 0 | 4 | _aChemotherapy, Adjuvant |
650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMethotrexate _xadministration & dosage |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeutropenia _xchemically induced |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aSurvival Analysis |
700 | 1 | _aMassie, C | |
700 | 1 | _aKerr, G | |
700 | 1 | _aLeonard, R C F | |
773 | 0 |
_tBritish journal of cancer _gvol. 89 _gno. 10 _gp. 1837-42 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bjc.6601366 _zAvailable from publisher's website |
999 |
_c14350164 _d14350164 |